A metabolic by-product that is more prevalent during fasting may supercharge immune cells as they fight infection and disease, reports an early stage study by Van Andel Institute scientists and collaborators. The findings, published today in Immunity, may pave the way for future personalized dietary recommendations to augment treatments for infection, cancer and other diseases.
Good Wednesday morning! In today’s edition of Your Daily Phil, we look at a new approach to caring for Holocaust survivors being taught at the PowerNET 2023: Mission Possible conference in Dallas, and feature an op-ed from Ted Sasson and.